Fast and accurate diagnostics from highly multiplexed sequencing assays
Preprint
Abstract
Scalable, inexpensive, accurate, and secure testing for SARS-CoV-2 infection is crucial for control of the novel coronavirus pandemic. Recently developed highly multiplexed sequencing assays that rely on high-throughput sequencing (HMSAs) can, in principle, meet these demands, and present promising alternatives to currently used RT-qPCR-based tests. However, the analysis and interpretation of HMSAs requires overcoming several computational and statistical challenges. Using recently acquired experimental data, we present and validate an accurate and fast computational testing workflow based on kallisto and bustools, that utilize robust statistical methods and fast, memory efficient algorithms for processing high-throughput sequencing data. We show that our workflow is effective at processing data from all recently proposed SARS-CoV-2 sequencing based diagnostic tests, and is generally applicable to any diagnostic HMSAs.Keywords
All Related Versions
- Published version: Scientific Reports, 10 (1), 1.
This publication has 8 references indexed in Scilit:
- Diagnostic Testing for the Novel CoronavirusJAMA, 2020
- Highly multiplexed single-cell RNA-seq by DNA oligonucleotide tagging of cellular proteinsNature Biotechnology, 2019
- MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indicesNature Methods, 2019
- The barcode, UMI, set format and BUStoolsBioinformatics, 2019
- BRB-seq: ultra-affordable high-throughput transcriptomics enabled by bulk RNA barcoding and sequencingGenome Biology, 2019
- Simultaneous epitope and transcriptome measurement in single cellsNature Methods, 2017
- Near-optimal probabilistic RNA-seq quantificationNature Biotechnology, 2016
- Starcode: sequence clustering based on all-pairs searchBioinformatics, 2015